Inission (INISS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
26 Aug, 2026Executive summary
Net sales increased 18.7% year-over-year to SEK 635 million, with organic growth of 7.4% and significant contributions from acquisitions such as Selteka.
EBITDA/EBITA rose to SEK 41 million, up SEK 16.8 million year-over-year, with margin improvement to 6.4%.
Earnings per share increased to SEK 1.3, up SEK 0.7 year-over-year.
Order intake for Q2 2026 rose to 719.3 MSEK from 516.9 MSEK, indicating stable run rates and supporting confidence in meeting the upper end of full-year guidance.
Both EMS and Power segments showed strong development, with EMS seeing robust growth in defense and datacenter markets, and Inission Power returning to profitability.
Financial highlights
Q2 2026 net sales: SEK 635 million (+18.7% YoY), with SEK 61 million from Selteka acquisition.
EBITDA/EBITA: SEK 41 million (up SEK 16.8 million YoY); margin: 6.4% (+1.9pp YoY).
EPS: SEK 1.3 (up SEK 0.7 YoY).
H1 2026 net sales: SEK 1,299 million; H1 EBITA: SEK 87.5 million.
Net debt at period end: SEK 517.2 million; equity ratio: 39.9%.
Outlook and guidance
Full-year sales expected at the higher end of SEK 2.3–2.5 billion guidance, with profitability maintained at current levels.
Medium-term targets: annual growth above 15% (10% organic, 5% via acquisitions), EBITA margin above 9%.
Order book and book-to-bill ratio of 1.1 support confidence in margin targets.
Cautious optimism due to global uncertainties, with risks from supply chain disruptions and inflation.
No change to guidance due to prudence and seasonal effects, but potential to overshoot exists.
Latest events from Inission
- Q1 2026 saw strong sales, margin growth, and robust order intake, signaling market recovery.INISS
Q1 2026 - 2025 revenue rose to SEK 2,206.2 million, with strong cash flow and a positive 2026 outlook.INISS
Q4 2025 - Sales fell 6.2%, but order intake, cash flow, and acquisitions signal H2 recovery.INISS
Q2 2025 - Revised targets and integration efforts position the company for renewed growth next year.INISS
ABGSC Investor Days - Sales and EBIT declined in Q3 2024, with cost cuts and revised targets amid market headwinds.INISS
Q3 2024 - Q2 sales up 1.4% to 570 MSEK, but organic growth and margins declined.INISS
Q2 2024 - Targeting 15% annual growth and 9% EBITDA margin, leveraging acquisitions and mega trends.INISS
CMD 2025 - Order intake up, but sales and margins fell; cost cuts and Nasdaq listing support cautious optimism.INISS
Q1 & AGM 2025 - Sales and margins fell, but order intake and cash flow rebounded; cost cuts and recovery expected.INISS
Q4 2024